Arosa Capital Management LP Decreased Diamondback Energy (FANG) Stake By $1.74 Million; Catalyst Pharmaceutical Partners (CPRX) Has 2.22 Sentiment

September 13, 2017 - By Adrian Mccoy

Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., is a development-stage biopharmaceutical company. The company has market cap of $216.46 million. The Firm is focused on developing and commercializing therapies for people with rare debilitating diseases. It currently has negative earnings. The Firm has three drugs in development: Firdapse, CPP-109 and CPP-115.

Arosa Capital Management Lp decreased Diamondback Energy Inc (FANG) stake by 3.08% reported in 2016Q4 SEC filing. Arosa Capital Management Lp sold 17,231 shares as Diamondback Energy Inc (FANG)’s stock declined 4.19%. The Arosa Capital Management Lp holds 542,785 shares with $54.85M value, down from 560,016 last quarter. Diamondback Energy Inc now has $9.17B valuation. The stock declined 0.44% or $0.41 reaching $93.08 per share. About 1.13M shares traded. Diamondback Energy Inc (NASDAQ:FANG) has risen 18.62% since September 13, 2016 and is uptrending. It has outperformed by 1.92% the S&P500.

Since March 15, 2017, it had 1 buy, and 1 sale for $146,746 activity. 2,400 shares were bought by WEST STEVEN E, worth $248,270. Pantermuehl Russell sold 2,000 shares worth $210,000. Plaumann Mark Lawrence also sold $101,524 worth of Diamondback Energy Inc (NASDAQ:FANG) on Tuesday, May 23. Another trade for 2,000 shares valued at $210,118 was sold by Dick Teresa L..

Investors sentiment decreased to 1.21 in 2016 Q4. Its down 0.05, from 1.26 in 2016Q3. It turned negative, as 32 investors sold FANG shares while 90 reduced holdings. 86 funds opened positions while 128 raised stakes. 90.81 million shares or 13.26% more from 80.18 million shares in 2016Q3 were reported. Redwood Investments Ltd stated it has 0.21% of its portfolio in Diamondback Energy Inc (NASDAQ:FANG). Macquarie Grp Limited has invested 0.09% of its portfolio in Diamondback Energy Inc (NASDAQ:FANG). Legal And General Grp Inc Public Ltd reported 57,386 shares. 871 were accumulated by Morgan Dempsey Management Ltd Liability Co. Parkside Fincl Bank And Tru, a Missouri-based fund reported 44 shares. Peregrine Asset Advisers reported 7,900 shares. Gam Ag invested in 25,444 shares. Enterprise Services Corporation stated it has 0% in Diamondback Energy Inc (NASDAQ:FANG). Moreover, Fjarde Ap has 0.07% invested in Diamondback Energy Inc (NASDAQ:FANG) for 30,894 shares. Gluskin Sheff & Associates has invested 1.97% in Diamondback Energy Inc (NASDAQ:FANG). Cwm Limited Liability Corp has invested 0.07% of its portfolio in Diamondback Energy Inc (NASDAQ:FANG). Landscape Capital Mngmt Limited Liability Corp holds 0.06% of its portfolio in Diamondback Energy Inc (NASDAQ:FANG) for 4,365 shares. 75,271 were accumulated by State Of Wisconsin Invest Board. First Lp has invested 0.08% in Diamondback Energy Inc (NASDAQ:FANG). Teachers Retirement System Of The State Of Kentucky invested in 0.04% or 30,850 shares.

Among 34 analysts covering Diamondback Energy (NASDAQ:FANG), 29 have Buy rating, 0 Sell and 5 Hold. Therefore 85% are positive. Diamondback Energy had 77 analyst reports since July 21, 2015 according to SRatingsIntel. Northland Capital maintained the shares of FANG in report on Monday, August 21 with “Buy” rating. As per Tuesday, August 1, the company rating was maintained by BMO Capital Markets. Mizuho initiated it with “Buy” rating and $105 target in Thursday, October 6 report. The firm has “Outperform” rating given on Thursday, January 14 by Cowen & Co. Northland Capital maintained Diamondback Energy Inc (NASDAQ:FANG) on Monday, July 17 with “Buy” rating. The rating was maintained by Roth Capital with “Buy” on Thursday, July 27. The stock has “Buy” rating by Euro Pacific Capital on Wednesday, September 9. As per Tuesday, November 17, the company rating was maintained by Roth Capital. Iberia Capital Partners initiated the stock with “Outperform” rating in Friday, January 29 report. Howard Weil maintained the shares of FANG in report on Wednesday, January 13 with “Sector Outperform” rating.

Tanaka Capital Management Inc holds 1.38% of its portfolio in Catalyst Pharmaceuticals Inc for 589,883 shares. Broadfin Capital Llc owns 8.20 million shares or 0.96% of their US portfolio. Moreover, Venbio Select Advisor Llc has 0.24% invested in the company for 1.14 million shares. The New York-based Berson & Corrado Investment Advisors Llc has invested 0.12% in the stock. Baker Bros. Advisors Lp, a New York-based fund reported 5.10 million shares.